India Atorvastatin Market to grow at a steady rate During the Forecast Period
High prevalence of
cardiovascular diseases is expected to drive the growth of India atorvastatin
market during the forecast period.
According to
TechSci Research report, “India Atorvastatin Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet v/s Capsule), By
Distribution Channel (Online v/s Offline), By Application (Hypercholesterolemia,
Hypertriglyceridemia, Dyslipidaemia, Others), By Company, By Region, Forecast
& Opportunities, FY2026”, the India atorvastatin market
is expected to grow at a steady rate during the forecast period to control elevated
cholesterol levels. Growing acceptance of combination therapies using statin
with other cholesterol diminishing compounds is projected to act as another key
market driver. Atorvastatin combined with dietary modifications to prevent
cardiovascular events in patients with cardiac risk factors and abnormal lipid
profiles is further expected to drive the market growth during the forecast
period. Moreover, improving healthcare infrastructure is further expected to
fuel the market growth through FY2026. Furthermore, rising health consciousness
among consumers is estimated to boost India atorvastatin market growth. However,
adverse health effects associated with atorvastatin such as gastrointestinal
symptoms such as diarrhea, cold symptoms such as a runny or stuffy nose, joint
pain, insomnia, urinary tract infection, nausea, loss of appetite, indigestion
symptoms such as stomach discomfort or pain can restrict the market growth over
the next few years. Moreover,
increase in demand for effective treatment
alternatives can further reduce the usage and application of the drug thereby
hindering the market growth during the forecast period.
Browse XX market data Tables and XX Figures spread
through XXX Pages and an in-depth TOC on" India Atorvastatin Market"
https://www.techsciresearch.com/report/india-atorvastatin-market/5147.html
The India
atorvastatin market is segmented based on source, form, distribution channel,
application, company, and region. Based on form, the market can be fragmented
into tablets and capsules. The tablets segment is expected to dominate the
market in the forthcoming years on account of several advantages like, cost
effectiveness, high stability and have longer shelf life. In terms of applications,
the market is split into hypercholesterolemia, hypertriglyceridemia, dyslipidemia,
others. Among them, dyslipidemia segment is projected to grow at high CAGR in
the next 5 years which can be ascribed to its use for the treatment of
several types of dyslipidaemias. Dyslipidaemia describes high level of plasma
cholesterol, triglycerides or both resulting in increased risk for the
development of atherosclerosis.
Jubilant Life
Sciences Ltd., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries
Ltd., Ind-Swift Labs Ltd., Morepen Laboratories Ltd., Anuh Pharma Ltd., Cadila
Pharmaceuticals Ltd., Pfizer Limited, Teva API India Limited, Lupin Limited and others are
some of the leading players operating in India atorvastatin market. Companies
operating in the market are using organic strategies such as product launches,
mergers and collaborations to boost their share and increase their geographic
reach.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5147
Customers can
also request for 10% free customization on this report.
“India atorvastatin market is
expected to witness steady growth during the forecast period on account of rising
cases of dyslipidemia. Along with this, approval of mass production of drugs
from federal agencies is further forecasted to bode well for the growth of atorvastatin
API market in the country. Moreover, growing consumer preference for
over-the-counter drugs is further expected to create lucrative opportunities
for the market growth of India Atorvastatin market over the next five years.” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based India
management consulting firm.
“India Atorvastatin Market By Source (In-house
v/s Contract Manufacturing Organizations), By Form (Tablet v/s Capsule), By
Distribution Channel (Online v/s Offline), By Application
(Hypercholesterolemia, Hypertriglyceridemia, Dyslipidaemia, Others), By
Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India atorvastatin
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in India atorvastatin market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]